Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home / Training / Seminars and Symposia / Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol)

Metabolomics in exploratory toxicology: Consequences of treatment with the candidate chemopreventive agent pentamethylchromanol (PMCol)

Jonathan McDunn, PhD., Associate Director, Diagnostics Research and Development at Metabolomic Inc. and Adjunct Associate Professor of Biomedical Engineering, UNC-Chapel Hill
When Feb 20, 2013
from 02:00 PM to 03:00 PM
Where G-605 Koury
Add event to calendar iCal

Sponsored by the Center for Environmental Health and Susceptibility